Spravato Ruined My Life: The Side Effects You Need to Know

Sprovato Ruined My Life | Sprovato Side Effects & Risks

Welcome to California Prime Recovery blog, your premier addiction and mental health treatment center located in Orange County, CA.

Spravato is a nasal spray treatment designed to help individuals with treatment-resistant depression, offering a new approach to managing severe depressive symptoms. It can provide significant relief within days of the first treatment, which is notably quicker compared to traditional antidepressants. However, like any medication, it comes with potential side effects and risks that require careful consideration. From increased blood pressure, chest pain, and shallow breathing to more serious concerns like aneurysmal vascular disease and suicidal thoughts, the need for a thorough risk evaluation is crucial before starting Spravato treatment. Individuals with blood vessel disease should avoid Spravato due to risks associated with high blood pressure and possible complications. Administered in certified healthcare settings under the guidance of a licensed healthcare professional, Spravato is part of a restricted program designed to ensure safety. In this blog, we’ll explore the most common side effects, how Spravato affects the body, and the potential risks involved in treatment sessions to help you make informed decisions about your mental health care and why individuals say “Spravato ruined my life”

What is Spravato Drug?

Spravato is a prescription medication used to treat adults with treatment-resistant depression (TRD) or major depressive disorder (MDD) with suicidal thoughts. It contains esketamine, a form of ketamine, and is administered as a nasal spray under medical supervision in a certified healthcare setting. Unlike Spravato, ketamine infusions are administered intravenously and have shown potential benefits for alleviating symptoms of treatment-resistant depression, though they require proper support and follow-up care to avoid adverse experiences. Spravato works by targeting glutamate, a chemical in the brain, to promote rapid symptom relief for severe depression. It is often used alongside oral antidepressants as part of a comprehensive treatment plan. While effective for some, it carries risks, including potential side effects like dizziness, dissociation, and increased blood pressure. Individuals with blood vessel disease should inform their healthcare provider before starting Spravato due to potential risks.

Why Do People Say Spravato Ruined My Life?

Some individuals say, “Spravato ruined my life,” due to adverse experiences with the medication. While Spravato can provide rapid relief for treatment-resistant depression, it is not without risks. Spravato treatments often require more frequent visits and longer monitoring durations, which can contribute to negative experiences. Common concerns include severe side effects like dissociation, dizziness, worsening depression, or suicidal thoughts in certain cases. Individuals with blood vessel disease may experience heightened risks and should consult their healthcare provider. Others may struggle with the financial burden of treatment, as Spravato can be expensive and often requires ongoing use. Additionally, some individuals report feeling emotionally detached or unable to return to their baseline after using the medication. These negative experiences highlight the importance of thorough evaluation, proper monitoring, and clear communication with healthcare providers to ensure Spravato is the right treatment option.

Spravato Nasal Spray Brands and Common References

1. Spravato (Brand Name)
   • FDA-approved esketamine nasal spray for treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts.
   • Manufactured by Janssen Pharmaceuticals, a division of Johnson & Johnson.
2. Esketamine (Generic Name)
   • The active ingredient in Spravato, a derivative of ketamine.
   • Works on the glutamate system to rapidly reduce depressive symptoms.
3. “Nasal Ketamine” (Informal Nickname)
   • Refers to Spravato’s administration method as a nasal spray.
   • Not an official name but used to describe its similarity to ketamine treatments.
4. “Ketamine Spray” (Casual Reference)
   • Another informal term sometimes used to describe Spravato.
   • Important to note: Spravato is distinct from generic ketamine therapies, which are not FDA-approved for depression.
5. Janssen Esketamine
   • Occasionally referred to by the pharmaceutical company name associated with its production.

While some casual nicknames exist, “Spravato” is the official and most widely recognized term for the medication.

Spravato Types, Dosages, and Dosage Guidelines

Types of Spravato: Spravato is available as a nasal spray for supervised administration in certified healthcare facilities. It is used in conjunction with oral antidepressants.

Available Dosages of Spravato:

1. 56 mg per dose
   • Used for the initial starting dose in treatment.
2. 84 mg per dose
   • Common maintenance dose, depending on individual needs and tolerability.

Each dose consists of multiple sprays administered in a single session under medical supervision.

Dosage Guidelines:

1. Initial Phase (Induction Phase):
   • Week 1-4:
     • Day 1 Starting Dose: 56 mg.
     • Subsequent doses: 56 mg or 84 mg, based on patient response.
     • Administered twice per week.
2. Maintenance Phase:
   • Week 5-8:
     • One dose (56 mg or 84 mg) administered once weekly.
   • Week 9 and Beyond:
     • One dose (56 mg or 84 mg) every 1-2 weeks, depending on patient progress and healthcare provider recommendations.

Important Notes:

• Spravato must always be taken under the supervision of a certified healthcare provider in a medically equipped setting.
• Dosage may be adjusted based on individual response, side effects, and the severity of depression.
• Patients are monitored for at least two hours after administration due to potential side effects like sedation, dissociation, or blood pressure changes.

Always follow your healthcare provider’s guidance when using Spravato.

How Long Does Sprovato Stay in Your System?

Spravato (esketamine) has a half-life of 7 to 12 hours, meaning it takes this time for half of the drug to be eliminated from the body. On average, Spravato can stay in your system for approximately 35 to 60 hours after a single dose, with its active metabolite, norketamine, potentially lasting slightly longer due to its half-life of 8 to 16 hours. Factors like dosage, frequency of use, metabolism rate, and overall health can influence how long it remains detectable. Always consult your healthcare provider for concerns about its duration or effects.

Sprovato Onset and Duration

Spravato (esketamine) has a rapid onset of action, with noticeable effects often occurring within 2 hours after administration. This quick onset is one of the reasons it is used for treatment-resistant depression and major depressive disorder with suicidal thoughts. The duration of its effects varies by individual but generally lasts several days, with most patients experiencing relief for 5 to 7 days after a single dose. Regular dosing as part of a supervised treatment plan helps maintain its therapeutic effects over time.

How Long is Sprovato Detectable in Your System?

Spravato (esketamine) is typically detectable in your system for 35 to 60 hours after a single dose, based on its half-life of 7 to 12 hours. This means it takes approximately 5 half-lives for the drug to be fully eliminated from the body. Its active metabolite, norketamine, which has a longer half-life of 8 to 16 hours, may remain detectable for slightly longer. Factors such as dosage, frequency of use, metabolism rate, and individual health conditions can influence how long Spravato stays in your system. Always consult your healthcare provider for specific guidance.

Spravato Efficacy and Uses for Treatment Resistant Depression

How Does Sprovato Work in the Brain and Body?

Spravato (esketamine) works by targeting the glutamate system in the brain, which plays a critical role in mood regulation and neural communication. Unlike traditional antidepressants that focus on serotonin, norepinephrine, or dopamine, Spravato binds to NMDA receptors, a type of glutamate receptor. This binding leads to increased glutamate release, which enhances the formation and strengthening of neural connections (synaptic plasticity). These changes help restore brain pathways disrupted by depression, providing rapid symptom relief.

In the body, Spravato is absorbed through the nasal mucosa and quickly enters the bloodstream. Its effects include sedation, dissociation, and changes in blood pressure, which is why it is administered under medical supervision. By addressing depression through a different mechanism than traditional antidepressants, Spravato provides an alternative option for individuals with treatment-resistant depression or acute suicidal ideation.

Sprovato Controlled Substance Classification

Spravato (esketamine) is classified as a Schedule III controlled substance under the Controlled Substances Act. This classification indicates it has a moderate potential for abuse and psychological or physical dependence, though less so than Schedule I or II substances. Due to these risks, Spravato is only administered in certified healthcare settings under strict medical supervision to ensure safe use and minimize the potential for misuse.

Mental Health Side Effects and Risks of Spravato

Short-Term Side Effects:

• Dissociation or feeling disconnected from reality
• Anxiety or restlessness
• Worsening of depressive symptoms or suicidal thoughts in some cases. Individuals with blood vessel disease may experience heightened risks and should consult their healthcare provider.
• Confusion or difficulty thinking clearly

Long-Term Risks:

• Potential for dependency or misuse due to its classification as a controlled substance
• Cognitive impairments, such as memory or concentration issues, with prolonged use
• Increased risk of mood instability if not closely monitored
• Rare but possible worsening of mental health conditions in certain individuals

Close medical supervision is essential to minimize risks and ensure Spravato’s safe use for mental health treatment.

Prevalence of Sprovato

Spravato is increasingly used as a treatment option for adults with treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts. Since its FDA approval in 2019, its use has grown in certified healthcare facilities due to its rapid symptom relief for those unresponsive to traditional antidepressants. However, its prevalence remains limited by strict administration guidelines, high costs, and the need for medical supervision.

Does Sprovato Cause Weight Gain or Increased Blood Pressure?

Spravato is not commonly associated with weight gain. Unlike many traditional antidepressants, weight changes are not a significant reported side effect. However, individual experiences may vary, and any concerns should be discussed with a healthcare provider.

Does Sprovato Make You Dizzy?

Yes, dizziness is a common side effect of Spravato. Many patients experience dizziness shortly after administration, as it affects the central nervous system. This is why Spravato is administered under medical supervision, with patients monitored for at least two hours after each dose. If dizziness persists or worsens, consult your healthcare provider.

Sprovato and Alcohol Use

Using Spravato and alcohol together is not recommended. Alcohol can enhance the sedative and depressant effects of Spravato, increasing the risk of dizziness, drowsiness, impaired judgment, and difficulty concentrating. Combining the two may also elevate the risk of severe side effects, such as respiratory problems, confusion, or loss of consciousness. To ensure safety and maximize the effectiveness of treatment, patients should avoid alcohol while using Spravato and discuss any concerns with their healthcare provider.

Can You Take Sprovato While Pregnant?

Spravato is not recommended during pregnancy unless the potential benefits outweigh the risks. There is limited research on its effects on pregnancy and fetal development, but it may pose risks, including potential harm to the fetus. Additionally, Spravato can cause sedation and blood pressure changes, which may impact maternal health. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their healthcare provider to make an informed decision about treatment.

Can Sprovato be Abused?

Yes, Spravato (esketamine) can be abused. As a derivative of ketamine, it has dissociative and hallucinogenic properties that some individuals may misuse. For this reason, Spravato is classified as a Schedule III controlled substance, indicating a moderate potential for abuse and dependence. To minimize this risk, it is only administered in certified healthcare facilities under strict medical supervision, and patients are monitored during and after each session. If you have concerns about misuse or dependency, consult your healthcare provider.

Sprovato Withdrawal Symptoms

Spravato (esketamine) withdrawal symptoms can occur, especially if the medication is stopped abruptly after long-term use. Common symptoms may include:

• Mood changes: Increased depression, irritability, or anxiety.
• Physical symptoms: Fatigue, headaches, or nausea.
• Cognitive issues: Difficulty concentrating or feeling “foggy.”
• Cravings: A desire to use Spravato or related substances due to its potential for psychological dependence.

While withdrawal symptoms are generally mild compared to other controlled substances, they can still be uncomfortable. To minimize withdrawal effects, healthcare providers may recommend tapering off treatment gradually under medical supervision. Always consult your doctor before discontinuing Spravato.

Can You Overdose on Sprovato?

Yes, it is possible to overdose on Spravato (esketamine). An overdose can cause severe sedation, dangerously high blood pressure, dissociation, or loss of consciousness. Due to these risks, Spravato is only administered under strict medical supervision in certified healthcare facilities, ensuring patients are closely monitored for safety. If you suspect an overdose, seek immediate medical attention.

Is Sprovato Addictive?

Yes, Spravato (esketamine) can be addictive. As a derivative of ketamine, it has the potential for misuse, psychological dependence, and addiction, especially when not used as prescribed. To reduce this risk, Spravato is classified as a Schedule III controlled substance and is only administered in certified healthcare facilities under strict supervision. Patients with a history of substance abuse should discuss their risks with their healthcare provider before starting treatment.

Can Sprovato Cause Suicidal Ideation or Risk of Suicidal Thoughts?

Yes, Spravato (esketamine) may cause or worsen suicidal ideation in some individuals, particularly during the early stages of treatment. Although it is designed to reduce depressive symptoms, including suicidal thoughts, certain patients may experience increased emotional distress or mood changes. For this reason, Spravato is administered under medical supervision, and patients are closely monitored for any signs of worsening depression or suicidal thoughts. If such symptoms occur, it is important to inform a healthcare provider immediately.

Can Sprovato Cause Mood Swings?

Yes, Spravato (esketamine) can cause mood swings in some individuals. As it affects brain chemicals involved in mood regulation, patients may experience emotional highs, irritability, or sudden changes in mood, especially early in treatment. While these effects are usually temporary, they can be distressing. Regular monitoring by a healthcare provider helps manage these symptoms and ensures the treatment remains safe and effective. If mood swings become severe or persistent, it is important to inform your doctor immediately.

Can Sprovato Cause Serious Allergic Reactions?

Yes, Spravato (esketamine) can cause serious allergic reactions, though they are rare. Symptoms of an allergic reaction may include rash, itching, swelling (especially of the face, tongue, or throat), severe dizziness, or difficulty breathing. If any of these symptoms occur, seek immediate medical attention. It is essential to inform your healthcare provider of any known allergies before starting Spravato to minimize the risk of an allergic reaction.

Spravato Drug Interactions with Medications

Spravato (esketamine) can interact with several medications, potentially increasing the risk of side effects or altering its effectiveness. Key interactions include:

1. Central Nervous System (CNS) Depressants:
   • Medications such as benzodiazepines, opioids, or alcohol can enhance sedation, dizziness, and respiratory depression when combined with Spravato.
2. Blood Pressure Medications:
   • Spravato may cause temporary increases in blood pressure, which can be risky if taken with antihypertensive drugs or medications affecting blood pressure regulation.
3. Stimulants:
   • Combining Spravato with stimulants like amphetamines can increase the risk of elevated blood pressure or heart rate.
4. Antidepressants (SSRIs, SNRIs, MAOIs):
   • While Spravato is often used alongside oral antidepressants, certain combinations may require close monitoring to avoid side effects or serotonin syndrome.
5. Drugs Affecting Liver Enzymes (CYP Enzymes):
   • Medications that influence liver enzymes, such as antifungals or certain antibiotics, can affect how Spravato is metabolized, altering its effectiveness or duration in the system.

Always disclose all medications and supplements you are taking to your healthcare provider before starting Spravato to avoid potential interactions and ensure safe treatment.

Responsible Use of Spravato

Spravato (esketamine) should always be used under the guidance of a certified healthcare provider in a controlled medical setting. To ensure responsible use, follow these guidelines:

1. Medical Supervision:
   • Spravato is administered in certified treatment centers, where patients are monitored for at least two hours after each dose to manage potential side effects like dizziness, dissociation, or blood pressure changes.
2. Follow Prescribed Schedule:
   • Adhere strictly to the treatment plan provided by your doctor, including the frequency and dosage of Spravato.
3. Avoid Alcohol and Certain Drugs:
   • Do not use alcohol, recreational drugs, or medications that may interact with Spravato, as they can increase risks like sedation or mood instability.
4. Report Side Effects:
   • Inform your healthcare provider about any side effects, mood changes, or unusual symptoms, especially if they persist or worsen.
5. Screen for Substance Abuse History:
   • Discuss any personal or family history of substance misuse with your provider to mitigate the risk of dependence or misuse.
6. Regular Mental Health Evaluations:
   • Participate in follow-up appointments to assess the effectiveness of the treatment and adjust the plan if necessary.

Spravato, administered in certified healthcare settings to treat depressive symptoms, may lead to side effects such as energy increased blood pressure, self or body sleepiness, a disconnected self or surroundings feeling, frequent daytime urination nightmares, behavior chest pain, trouble breathing, and sudden severe headache, requiring close monitoring.

Prescription Medication Addiction and Treatment Options

Prescription Medication Addiction occurs when individuals misuse prescribed drugs, leading to dependency. Commonly abused medications include opioids, benzodiazepines, stimulants, and certain antidepressants. Addiction can develop due to increased tolerance, cravings, or using the medication in ways not prescribed, such as taking higher doses or combining it with other substances.

Treatment Options for Prescription Medication Addiction

1. Medical Detox:
   • Supervised detox helps manage withdrawal symptoms safely and reduces health risks associated with stopping medication suddenly.
2. Inpatient Rehabilitation:
   • Structured programs provide 24/7 care, therapy, and support in a safe, controlled environment.
3. Outpatient Programs:
   • Flexible treatment options for those who do not require inpatient care, including therapy sessions, medication-assisted treatment (MAT), and counseling.
4. Medication-Assisted Treatment (MAT):
   • Medications like Suboxone, methadone, or naltrexone can help manage cravings and withdrawal for opioid addiction, while others like disulfiram or acamprosate are used for alcohol dependence.
5. Therapy and Counseling:
   • Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and group therapy address the underlying causes of addiction and develop healthy coping mechanisms.
6. Support Groups:
   • Peer support groups like Narcotics Anonymous (NA) or SMART Recovery offer ongoing community support and accountability.
7. Aftercare and Relapse Prevention:
   • Long-term care plans, including therapy and regular check-ins, help prevent relapse and maintain recovery.

Recovery is a journey that requires personalized care. Working with addiction specialists ensures a comprehensive approach to overcoming prescription medication addiction and rebuilding a healthy life.

Learn More About Treatment Types and Services in Our Guides →

Does Insurance Cover Prescription Drug Addiction Treatment?

Yes, most insurance plans cover prescription drug addiction treatment, including medical detox, inpatient rehab, outpatient programs, and therapy. Coverage varies based on the provider and plan, but the Mental Health Parity and Addiction Equity Act requires many insurers to offer equal coverage for addiction treatment as they do for other medical conditions. It’s essential to contact your insurance provider to understand your benefits and out-of-pocket costs for addiction treatment services.

Conclusion

Spravato offers a promising option for those struggling to treat depression when other medications have failed. However, its side effects, such as unusual drowsiness, vivid dreams, tingling sensations, and even the risk of suicidal thoughts, highlight the importance of proper risk evaluation and close monitoring. With potential concerns ranging from breathing problems and chest pain to the impact of other medications like birth control or street drugs, a licensed healthcare professional plays a critical role in guiding patients through the process. Whether it’s understanding how Spravato affects your body, addressing bladder problems, or managing energy increases and blood pressure spikes, a mitigation strategy is key to minimizing risks. Always consult with your healthcare provider to weigh the benefits and risks of taking Spravato, ensuring that your treatment aligns with your physical and mental health needs.